Systemic therapy and active surveillance can be viable options for patients with TGCT, as one expert explained.

Tenosynovial giant cell tumors, or TGCTs, are non-malignant, but have plenty in common with cancer in terms of impacting ...

Patients with TGCTs, or tenosynovial giant cell tumors, often have to deal with pain and discomfort as a result of the ...

In a conversation with CURE® as part of the “Speaking Out” video series, Stern explained that the ideal multidisciplinary ...

There are not many patients with tenosynovial giant cell tumors, or TGCTs, with one expert telling CURE® that “about one in 1 ...

While I was receiving treatment for endometrial cancer, I received so much support from friends, coworkers and people from my church.

From 2010 through 2017 she received her annual mammogram screenings. During this seven-period, no physician noted that many ...

Compassionate, caring and courageous are the words I would use to describe Marianne Smith, RN, ONC. Compassionate, caring and ...

Luca Biagiotti, RN, did everything he could to build a relationship with this patient and make him feel less lonely at the ...

Under her exceptional leadership in oncology navigation, the impact on patient outcomes has been nothing short of ...

Treatment with the CAR-T cell therapy Carvykti has been reported to improve survival among some patients with multiple ...

When I started receiving chemotherapy for stage 3B lung cancer, I initially felt hopeless. I felt a change in my outlook on ...